Frontiers in Endocrinology (Jul 2023)

Effectiveness of a real-life program (DIAfit) to promote physical activity in patients with type 2 diabetes: a pragmatic cluster randomized clinical trial

  • Amar Arhab,
  • Nicolas Junod,
  • Nicolas Junod,
  • Nicolas Junod,
  • Jean-Benoit Rossel,
  • Olivier Giet,
  • Olivier Giet,
  • Frederic Sittarame,
  • Sandra Beer,
  • Daniela Sofra,
  • Dominique Durrer,
  • Humberto Delgado,
  • Montserrat Castellsague,
  • Markus Laimer,
  • Jardena J. Puder

DOI
https://doi.org/10.3389/fendo.2023.1155217
Journal volume & issue
Vol. 14

Abstract

Read online

IntroductionThe aim of this study was to evaluate the effectiveness of a real-life clinical physical activity program (DIAfit) on improving physical fitness, body composition, and cardiometabolic health in an unselected population with type 2 diabetes mellitus, and to compare the effects of two variants a different exercise frequencies on the same outcomes.Research design and methodsThis was a cluster randomized-controlled assessor-blind trial conducted in 11 clinical centres in Switzerland. All participants in the clinical program with type 2 diabetes were eligible and were randomized to either standard (3 sessions/week for 12 weeks) or alternative (1 session/week for the first four weeks, then 2 sessions/week for the rest of 16 weeks) physical activity program each consisting of 36 sessions of combined aerobic and resistance exercise. Allocation was concealed by a central office unrelated to the study. The primary outcome was aerobic fitness. Secondary outcome measures included: body composition, BMI, HbA1c, muscle strength, walking speed, balance, flexibility, blood pressure, lipid profile.ResultsAll 185 patients with type 2 diabetes (mean age 59.7 +-10.2 years, 48% women) agreed to participate and were randomized in two groups: a standard group (n=88) and an alternative group (n=97)). There was an 11% increase in aerobic fitness after the program (12.5 Watts; 95% CI 6.76 to 18.25; p<0.001). Significant improvements in physical fitness, body composition, and cardiometabolic parameters were observed at the end of the DIAfit program (improvements between 2-29%) except for lean body mass, triglycerides and cholesterol. No differences were observed between both programs, except for a larger weight reduction of -0.97kg (95% CI -0.04 to -1.91; p=0.04) in the standard program.ConclusionsBoth frequency variants of the nation-wide DIAfit program had beneficial effects on physical fitness, HbA1c, body composition, and blood pressure in type 2 diabetes patients and differences were negligible.Clinical trial registrationclinicaltrials.gov, identifier NCT01289587.

Keywords